EUVIMEDEUVIMED entdecken
Crossref

Multi‐Target Approach for Drug‐Resistant Epilepsy: An In Silico Exploration of Promising Phytochemicals

Nidhi Khedpande, Nachiket Joshi, RajaSekhar Reddy Alavala, Kalyani Barve iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202501359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Nidhi Khedpande und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's Narsee Monjee Institute of Management Studi…. Hauptthemen laut MEDLINE: Phytochemicals, Drug Resistant Epilepsy, Proanthocyanidins, Catechin. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nucleotide‐binding domain, leucine‐rich‐containing family, pyrin domain‐containing‐3 (NLRP3) inflammasome pathway, involving NLRP3 protein and caspase‐1, is reported to be involved in the progression of epilepsy into drug‐resistant epilepsy (DRE). Overactivation of ABC transporter proteins in neuronal cells as a result of NLRP3 activation leads to the efflux of the anti‐seizure medications, rendering them ineffective. This work aims to identify novel hit molecules that can halt neuroinflammation as well as potentiate the action of anti‐seizure medications. Initially, molecular docking studies evaluated procyanidin binding against NLRP3, caspase‐1, and ABC proteins as −177.001, −126.842, and −143.671. Procyanidin was further subjected to MD simulations for 100 ns, revealing RMSD values below 5 Å for procyanidin in complex with ABC and caspase proteins, whereas with NLRP3, it was below 2.5 Å. Procyanidin showed a Δ G binding value of −82.10142857 ± 15.07 with caspase, −61.9005 ± 9.95 with NLRP3, and −101.021 ± 5.27 kcal/mol with ABC protein. Procyanidin was predicted to bear good plasma‐protein binding and a class 5 acute toxicity class ligand. It also showed a band energy gap of −4.873 eV, which suggested its stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhytochemicalsDrug Resistant EpilepsyProanthocyanidinsCatechinBiflavonoidsAnticonvulsantsMolecular Docking SimulationHumansNLR Family, Pyrin Domain-Containing 3 ProteinCaspase 1Molecular Structure

Stichwörter der Autor:innen

HOMO–LUMO energydrug discoveryleucine‐rich‐containing familymolecular dockingmolecular dynamicsnucleotide‐binding domainpyrin domain‐containing‐3 (NLRP3) inflammasome

Substanzen

PhytochemicalsNLR Family, Pyrin Domain-Containing 3 ProteinProanthocyanidinsprocyanidinCatechinBiflavonoidsCaspase 1Anticonvulsants

Autor:innen und Institutionen

  • Department of Pharmacology, Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Mumbai, India.
  • Department of Pharmaceutical Chemistry, Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Mumbai, India.

ORCID-Profile: Kalyani Barve

Zitieren

APA

Khedpande, N., Joshi, N., Alavala, R. R., & Barve, K. (2025). Multi‐Target Approach for Drug‐Resistant Epilepsy: An In Silico Exploration of Promising Phytochemicals. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501359

Vancouver

Khedpande N, Joshi N, Alavala RR, Barve K. Multi‐Target Approach for Drug‐Resistant Epilepsy: An In Silico Exploration of Promising Phytochemicals. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202501359

BibTeX
@article{Khedpande2025,
  author = {Khedpande, Nidhi and Joshi, Nachiket and Alavala, RajaSekhar Reddy and Barve, Kalyani},
  title = {Multi‐Target Approach for Drug‐Resistant Epilepsy: An In Silico Exploration of Promising Phytochemicals},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202501359}
}
Kostenlos starten →